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In recent years, the need for enhanced rigor, reproducibility, and transparency in 
biomedical research has been the topic of much discussion. The National Institutes of 
Health (NIH) led the way in this conversation with issuance of the NIH guidelines for rigor 
and reproducibility, which have been mandated for all grant applications since 2016 (1,2). 
In support of this initiative, a recent review article by Hart and Powers, published 
in Diabetologia (3), with an accompanying editorial copublished 
in Diabetes and Diabetologia by Poitout et al. (4,5) highlighted the need for improved 
standardization of human islet data and its reporting in scientific 
publications. Diabetologia and Diabetes have initiated a checklist that is now required at 
the time of manuscript submission. At a minimum, the source and isolation center, a 
unique identifier number for each human islet preparation, and key demographic/clinical 
data must be included. Although not mandatory, the editorial encourages the inclusion of 
additional data, such as the cause of donor death, measurements of islet purity and 
viability, functional measures, ischemia duration, and culture time. 
Since 2004, the Integrated Islet Distribution Program (IIDP) has served as the main 
source of human islets for research in the U.S. (6–8). Directed by Joyce C. Niland at the 
City of Hope in Duarte, CA, the IIDP is funded by the National Institutes of Diabetes and 
Digestive and Kidney Diseases (NIDDK) and the JDRF. To date, the IIDP has distributed 
over 250 million islets, serving more than 400 islet studies across nine different countries, 
with the resulting research yielding more than 700 publications. Thus, the IIDP is a major 
contributor to the “human islet research ecosystem” as described by Hart and Powers (3), 
as well as an avid supporter of improved standards for reporting of human islet data. 
In recognition of the growing need for improved assessment of human islet function and 
quality, the NIH and IIDP initiated the Human Islet Phenotyping Program (HIPP) in 2016. 
The HIPP program is located at Vanderbilt University in Nashville, TN, and is directed by 
Marcela Brissova, with Carmella Evans-Molina, Co-Principal Investigator of the IIDP, 
serving as the HIPP liaison. The HIPP receives a sample of human islets from each IIDP-
supported islet isolation. As depicted in the analysis workflow (Fig. 1A), the HIPP 
conducts postshipment assessment of islet morphology, viability, and software-guided 
measurement of islet purity and number. These data are then integrated with in vitro islet 
 
 
functional analysis by perifusion, which simultaneously captures insulin and glucagon 
secretory profiles with high temporal resolution. Because human islet preparations vary 
in terms of their composition, the islet functional data can be further correlated with 
composition of three major islet cell types, α, β, and δ cells, measured independently by 
immunofluorescence. When possible, the HIPP also collects and stores samples for 
future investigation, including frozen samples of handpicked islets (for RNA and protein 
analysis) and frozen samples of islet preparations (for DNA analysis). The sample 
resource is under development and will become available in the near future. In December 
2018, the HIPP data were released to IIDP-affiliated investigators. To date, the HIPP has 
analyzed nearly 200 islet preparations from a demographically diverse pool of donors 
(Fig. 1B). Synthesis of the rich data set generated by this unique resource can be 
leveraged by investigators to provide context for their own experiments and analyses, 
and their resulting data could potentially be integrated with IIDP–HIPP data in the future. 
Most importantly, the HIPP workflow yields standardized data that will enhance 
transparency and quality in human islet research. 
 
 
 
Figure 1 
The IIDP–HIPP integrates a broad spectrum of islet phenotypic features with donor 
characteristics. A: Analysis workflow performed by the HIPP on human islets from each 
IIDP-supported islet isolation. Human islets from the same preparation are distributed to 
HIPP and IIDP-affiliated investigators. B: The IIDP–HIPP database contains data from a 
large and demographically diverse pool of islet donors. Shown is the racial background 
 
 
of islet donors for 198 preparations analyzed by HIPP since 2016. C: Steps required for 
automated publication checklist generation from the IIDP Data Center. The IIDP–HIPP 
database and the automated online tool for checklist generation can be accessed by 
authorized IIDP users through the dashboard of the IIDP password-protected website 
(https://iidp.coh.org/secure/isletavail/). 
As another recent enhancement to assist investigators in meeting the new mandatory 
criteria for reporting of human islet data as put forth by Diabetologia and Diabetes, the 
IIDP has developed an automated online tool to compile and export the mandated 
information for manuscript submission. All of the required data have been collected by 
IIDP-affiliated islet isolation centers since January 2010 and are available to investigators 
so that the information can be provided when submitting manuscripts 
to Diabetes/Diabetologia (and, possibly, additional journals in the future). Data on the 
functional assessment of the islet preparations, classed as “recommended information” 
in the reporting checklist, have been provided by the HIPP since July 2016. Using this 
online reporting tool, investigators will be able to directly export islet checklist data into an 
Excel spreadsheet that can be uploaded to the journal. Islet preparations are selected for 
inclusion in the checklist based on a unique Research Resource Identifier (RRID) (9) (Fig. 
1C). Both the IIDP–HIPP database and the automated online tool for checklist generation 
can be accessed by authorized IIDP users through the dashboard of the IIDP password-
protected website (https://iidp.coh.org/secure/isletavail/). 
Whereas efforts toward standardized reporting of human islet data are a critical first step 
in ensuring rigor and reproducibility in diabetes research, an unintended consequence of 
any new mandate can be an additional burden on investigators both in time and 
resources. Our hope is that the data provided by the IIDP isolation centers preshipment 
and the rich phenotyping data provided by the HIPP postshipment can assist investigators 
in meeting these new requirements. Other programs have begun similar initiatives to 
share phenotyping and multiomics data from isolated islets, including the Human 
Pancreas Analysis Program (HPAP) of the Human Islet Research Network (HIRN) and 
the Islet Core at the Alberta Diabetes Institute. Making these types of centrally collected 
data available can both enhance rigor and reproducibility and accelerate scientific 
 
 
discoveries. In addition, they provide cost savings to the diabetes research community by 
reducing the need for individual investigators to collect the same type of information 
and/or perform redundant assays. We believe that the recent IIDP–HIPP initiatives 
described here will help to set new standards in human islet research, and we are pleased 
to offer solutions that improve human islet research and satisfy new journal reporting 
requirements, without adding undue burden to individual investigators. 
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